IL1B and Cognitive impairment: For MWM test, treatment with IL-1β-siRNA significantly improved neonatal inflammation-induced cognitive impairment (Fig. 3D-3F, n= 15–24, *P = 0.012, ** P < 0.01, *** P < 0.001).